This is the first study to assess aPKCλ/ι expression in primary prostate cancer with metastatic disease.
A total of 43 patients with prostate cancer and its metastasis to the lymph node and/or bone were analyzed in this study.
We found no strong association between aPKCλ/ι expression and the prognosis of the patients.
Keywords: Hormonal therapy; Prostate cancer; aPKC.